posted on 2018-10-08, 11:34authored byClare Caraher, Antonia Sophocleous, Renwick J. Beattie, Olive M. O'Driscoll, Niamh M. Cummins, Orlaith Brennan, Fergal J. O'Brien, Stuart H. Ralston, Steven E.J. Bell, M.R. Towler, Aymen I. Idris
Osteoporosis is a common disease characterised by reduced bone mass and an increased risk of fragility fractures. Low bone mineral density is known to significantly increase the risk of osteoporotic fractures, however, the majority of non-traumatic fractures occur in individuals with a bone mineral density too high to be classified as osteoporotic. Therefore, there is an urgent need to investigate aspects of bone health, other than bone mass, that can predict the risk of fracture. Here, we successfully predicted association between bone collagen and nail keratin in relation to bone loss due to oestrogen deficiency using Raman spectroscopy. Raman signal signature successfully discriminated between ovariectomised rats and their sham controls with a high degree of accuracy for the bone (sensitivity 89%, specificity 91%) and claw tissue (sensitivity 89%, specificity 82%). When tested in an independent set of claw samples the classifier gave 92% sensitivity and 85% specificity. Comparison of the spectral changes occurring in the bone tissue with the changes occurring in the keratin showed a number of common features that could be attributed to common changes in the structure of bone collagen and claw keratin. This study established that systemic oestrogen deficiency mediates parallel structural changes in both the claw (primarily keratin) and bone proteins (primarily collagen). This strengthens the hypothesis that nail keratin can act as a surrogate marker of bone protein status where systemic processes induce changes.
Funding
Using the Cloud to Streamline the Development of Mobile Phone Apps
BBA - Molecular Basis of Disease;1864 (2), pp. 398-406
Publisher
Elsevier
Note
peer-reviewed
Other Funding information
IRC
Rights
This is the author’s version of a work that was accepted for publication in BBA - Molecular Basis of Disease . Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in BBA - Molecular Basis of Disease, 2018, 1864 (2), pp. 398-406, https://doi.org/10.1016/j.bbadis.2017.10.020